As expected, compared with the C57BL/6 mice, the vehicle-treated MRL/lpr mice displayed marked splenomegaly, while the PKM2-IN-treated MRL/lpr mice significantly reversed the results (Figures S15A, B). The gene discussed is PKM; the disease is Splenomegaly.